Sartorius Stedim Biotech's total assets for Q1 2025 were €8.30B, an increase of 0.57% from the previous quarter. FR:DIM total liabilities were €4.30B for the fiscal quarter, a 1.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.